With a Two-Year Revenue Growth of 252 Percent, PathogenDx Ranks No. 46 on Inc. Magazine’s List of the Southwest Region’s Fastest-Growing Private Companies


Companies on the 2022 Inc. 5000 Regionals Southwest list had an average growth rate of 154 percent

Scottsdale, Arizona–(Newsfile Corp. – March 15, 2022) – Inc. magazine revealed that PathogenDx, a U.S.-based biotechnology company that is setting a new standard in molecular testing through widespread adoption of its advanced microarray testing platform for the human diagnostics, food and agricultural industries, is No. 46 on its third annual Inc. 5000 Regionals Southwest list, the most prestigious ranking of the fastest-growing private companies based in Arizona, New Mexico, Oklahoma and Texas. Born of the annual Inc. 5000 franchise, this regional list represents a unique look at the most successful companies within the Southwest region economy’s most dynamic segment-its independent small businesses.

“We are thrilled to be named one of the fastest growing private companies in the Inc. Regional Southwest Series,” said PathogenDx Co-founder and CEO Milan Patel. “Compared to earlier generations of microarray technology, PathogenDx has invented and developed a New Generation microarray technology to enable multiplex testing of multiple pathogens in a single-well test to drive simplicity, at very low costs while deliver sequencing level accuracy and at high sample throughput for the human diagnostics, food safety, agricultural or the environment monitoring markets. Our company employs top-tier molecular scientists who have been credited with obtaining more than 70 patents, delivering new testing technologies at an unprecedented level. From COVID-19 and variant detection, to rapid identification of pathogenic contamination to improve food safety, and driving high levels of purity and safety in cannabis, while also the company’s technology drives reduction of less carbon footprint helping climate change through less use of plastics in lab testing – I couldn’t be more proud of our talented team and the work we’ve done together to address some of the world’s toughest challenges.”

The companies on this list show a remarkable rate of growth across all industries in the Southwest region. Between 2018 and 2020, these 141 private companies had an average growth rate of 154 percent and, in 2020 alone, they added 10,563 jobs and nearly $10.9 billion to the Southwest region’s economy. Companies based in the Austin, Texas, Scottsdale, Arizona, and Fort Worth, Texas, areas had the highest growth rate overall.

Complete results of the Inc. 5000 Regionals Southwest, including company profiles and an interactive database that can be sorted by industry, metro area, and other criteria, can be found at inc.com/southwest starting March 15, 2022.

“This year’s Inc. 5000 Regional winners represent one of the most exceptional and exciting lists of America’s off-the-charts growth companies. They’re disruptors and job creators, and all delivered an outsize impact on the economy. Remember their names and follow their lead. These are the companies you’ll be hearing about for years to come,” says Scott Omelianuk, editor-in-chief of Inc.

PathogenDx was also named in Fast Company‘s World Changing Ideas Awards 2021: Pandemic Response Finalists and Honorable Mentions for innovating its introduction of an expanded 96-well plate microarray, with improved sample preparation and streamlined data reporting and the introduction of a new, customized data analysis portal. The company recently launched an ‘Industry first‘ multiplex assay for rapid, affordable variant detection for SARS-CoV-2 with unmatchable capability to identify emerging variants and mutations. The company’s National Institute of Health (“NIH”)-supported technology would provide invaluable insight to guide scientific discovery and public health decision making – not someday, but today – and does so without the time and expense of sequencing.

More about Inc. and the Inc. 5000 Regionals

The 2022 Inc. 5000 Regionals are ranked according to percentage revenue growth when comparing 2018 and 2020. To qualify, companies must have been founded and generating revenue by March 31, 2018. They had to be U.S.-based, privately held, for-profit, and independent-not subsidiaries or divisions of other companies-as of December 31, 2019. (Since then, a number of companies on the list have gone public or been acquired.) The minimum revenue required for 2018 is $100,000; the minimum for 2020 is $1 million. As always, Inc. reserves the right to decline applicants for subjective reasons.

About Inc. Media
The world’s most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community to build great companies. Its award-winning multiplatform content reaches more than 50 million people each month across a variety of channels including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers and the credibility that helps them drive sales and recruit talent.

The associated Inc. 5000 Conference is part of a highly acclaimed portfolio of bespoke events produced by Inc. For more information, visit www.inc.com.

About PathogenDx
Headquartered in Scottsdale, Arizona, PathogenDx’s mission is to become the new standard in DNA-based testing through widespread adoption of its advanced microarray testing platform for the human diagnostics, food and agricultural industries. PathogenDx’s technology can rapidly identify and detect up to 50 pathogens all in a single test, in six hours providing triplicate data per analyte for certainty in results with a simple and easy process. The company’s DNA-testing products – Detectx™, Quantx™ and Envirox™ are disrupting the century-old practice of petri-dish testing to identify, detect and quantify pathogens that are a threat to human health, their ecosystem and the environment. This technology will help growing businesses deliver safer products and healthier lives, while preventing billions of dollars in losses from infection and contamination. For more information on how you can utilize this simple, powerful and inexpensive DNA-based pathogen testing, visit www.pathogendx.com.

Media Contact
Max Borchardt
[email protected]


To view the source version of this press release, please visit https://www.newsfilecorp.com/release/116596


Please enter your comment!
Please enter your name here